We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$55.2B
AUM Growth
-$1.5B
Cap. Flow
+$484M
Cap. Flow %
0.88%
Top 10 Hldgs %
16.38%
Holding
3,392
New
160
Increased
1,523
Reduced
1,437
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 11.79%
2 Financials 6.52%
3 Healthcare 5.69%
4 Consumer Discretionary 4.93%
5 Industrials 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODX
3201
Co-Diagnostics
CODX
$5.49M
$13K ﹤0.01%
408
-10
-2% -$378
DCFC
3202
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$11.4K ﹤0.01%
189
CGEN icon
3203
Compugen
CGEN
$221M
$11K ﹤0.01%
11,831
INTZ
3204
DELISTED
INTRUSION INC NEW
INTZ
$10.5K ﹤0.01%
29,997
+16,748
+126% +$5.84K
EMPD
3205
Empery Digital
EMPD
$74.5M
0
LILM
3206
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$9.72K ﹤0.01%
13,629
-1,200
-8% -$1.4K
DARE icon
3207
Dare Bioscience
DARE
$21.6M
$9.24K ﹤0.01%
1,667
-1
-0.1% -$8
RVLP
3208
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$8.92K ﹤0.01%
103,037
+73,518
+249% +$21.2K
DXYN
3209
DELISTED
Dixie Group Inc
DXYN
$8.89K ﹤0.01%
12,900
ATOS icon
3210
Atossa Therapeutics
ATOS
$23.6M
$8.86K ﹤0.01%
+802
New +$11.6K
XLE icon
3211
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
$8.8K ﹤0.01%
+200
New +$8.75K
OCGN icon
3212
Ocugen
OCGN
$465M
$7.7K ﹤0.01%
19,243
+7,500
+64% +$3.7K
CTXR icon
3213
Citius Pharmaceuticals
CTXR
$19.8M
$7.6K ﹤0.01%
444
BODI icon
3214
The Beachbody Company
BODI
$45.8M
$7.43K ﹤0.01%
504
BGMS
3215
Bio Green Med Solution Inc
BGMS
$4.97M
$7.38K ﹤0.01%
6
WOLF icon
3216
PUT
Wolfspeed
WOLF
$1.57B
$7.3K ﹤0.01%
+200
New +$10.5K
AKLI
3217
DELISTED
Akili Inc
AKLI
$6.83K ﹤0.01%
12,448
-200
-2% -$199
BRDS
3218
DELISTED
Bird Global, Inc.
BRDS
$6.29K ﹤0.01%
+10,672
New +$17.8K
ACB
3219
Aurora Cannabis
ACB
$216M
$6.17K ﹤0.01%
1,054
-137
-12% -$797
TAOX
3220
Tao Synergies Inc
TAOX
$27M
$5.37K ﹤0.01%
+488
New +$7.39K
AIFF
3221
Firefly Neuroscience
AIFF
$17.8M
$5.04K ﹤0.01%
650
WKHS icon
3222
Workhorse Group
WKHS
$34.1M
$4.95K ﹤0.01%
4
CATX icon
3223
Perspective Therapeutics
CATX
$363M
$4.79K ﹤0.01%
1,750
-100
-5% -$467
SIDU icon
3224
Sidus Space
SIDU
$266M
$4.73K ﹤0.01%
331
-20
-6% -$325
ENG
3225
DELISTED
ENGlobal Corp
ENG
$4.49K ﹤0.01%
1,658
-219
-12% -$608

Similar funds

Raymond James Financial Services Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Raymond James Financial Services Advisors held 3,392 positions worth $55.2B, down 2.7% from $56.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James Financial Services Advisors's Q3 2023 filing shows 160 new, 1,523 increased, 1,437 reduced and 131 closed positions. Its largest new stake was Invesco MSCI USA ETF: 829,157 shares worth $35.4M. The largest sale was iShares Core S&P Total US Stock Market ETF, an estimated $177M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q3 2023 buy was Invesco MSCI USA ETF: 829,157 shares worth $35.4M.
  • Raymond James Financial Services Advisors added most to Capital Group Dividend Value ETF in Q3 2023, an estimated $61M increase.
  • Raymond James Financial Services Advisors's biggest Q3 2023 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $177M.
  • Raymond James Financial Services Advisors fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $22.4M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 16% of its $55.2B portfolio in Q3 2023.
  • Raymond James Financial Services Advisors opened 160 new positions and closed 131 in Q3 2023.
  • Raymond James Financial Services Advisors's portfolio value fell 2.7% quarter-over-quarter to $55.2B.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.